FDTRX
Price
$187.31
Change
-$5.39 (-2.80%)
Updated
Feb 21 closing price
Net Assets
26.11B
GFAFX
Price
$76.03
Change
-$1.83 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

FDTRX vs GFAFX

Header iconFDTRX vs GFAFX Comparison
Open Charts FDTRX vs GFAFXBanner chart's image
Franklin DynaTech R6
Price$187.31
Change-$5.39 (-2.80%)
VolumeN/A
Net Assets26.11B
American Funds Growth Fund of Amer F1
Price$76.03
Change-$1.83 (-2.35%)
VolumeN/A
Net Assets304.33B
FDTRX vs GFAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDTRX vs. GFAFX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDTRX is a Hold and GFAFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 304B vs. FDTRX (26.1B). GFAFX pays higher dividends than FDTRX: GFAFX (0.45) vs FDTRX (0.00). FDTRX was incepted earlier than GFAFX: FDTRX (12 years) vs GFAFX (24 years). GFAFX is a more actively managed with annual turnover of: 31.00 vs. FDTRX (15.29). GFAFX has a lower initial minimum investment than FDTRX: GFAFX (250) vs FDTRX (1000000). FDTRX annual gain was more profitable for investors over the last year : 17.31 vs. GFAFX (12.28). FDTRX return over 5 years is better than : 84.38 vs. GFAFX (42.32).
FDTRXGFAFXFDTRX / GFAFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD0.8133.07826%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets26.1B304B9%
Annual Yield % from dividends0.000.45-
Returns for 1 year17.3112.28141%
Returns for 3 years46.1423.02200%
Returns for 5 years84.3842.32199%
Returns for 10 years275.9072.87379%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHRW100.880.46
+0.46%
C.H. Robinson Worldwide
AMPH31.28-0.02
-0.06%
Amphastar Pharmaceuticals
SNOA2.39-0.02
-1.03%
Sonoma Pharmaceuticals Inc
RSSS3.21-0.04
-1.23%
Research Solutions
CGEM9.03-0.12
-1.31%
Cullinan Therapeutics